People with Parkinsons have low glutathione levels in the brain, and boosting GSH may be an early measure to prevent this disease
FDA approves first drug for Parkinson disease psychosis
Clinical studies, such as the MANPOWER study, have shown that supplementing with polyenylphosphatidylcholine can significantly improve liver echogenicity and reduce fat accumulation in patients with non-alcoholic fatty liver disease (NAFLD), a condition that frequently co-occurs with metabolic dysfunction in chronic illness
"I don't normally use weight loss or dietary supplements but when weight keeps you from doing what you want you'll find any means to change that
Over time, this combination of appetite suppression and better blood sugar regulation can lead to consistent weight loss
To help the body adjust and reduce side effects, treatment usually begins with a low dose that is gradually increased over several weeks until the maintenance dose is reached